A comprehensive view of Medicines and Healthcare Products Regulatory Agency MHRA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
UK's MHRA grants full marketing authorization to Novavax's Nuvaxovid COVID-19 vaccine for individuals aged 12 and older; the approval expected to expedite the authorization process for updated vaccine variants in future
Published:
October 18, 2023
by Novavax Inc.
|
Roche's subcutaneous cancer therapy, Tecentriq SC, has been approved by the Medicines and Healthcare products Regulatory Agency in the UK; the therapy is a quicker, potentially more comfortable alternative to IV administration for cancer patients
Published:
August 31, 2023
by PharmaBiz
|
Ask us about our Government & Public Policy market view